IRMD
iRadimed Corporation
$92.94
+$0.84(+0.91%)
51
Overall
45
Value
45
Tech
65
Quality
Market Cap
$1.12B
Volume
101.19K
52W Range
$51.26 - $107.90
Target Price
$118.00
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $32.5M | $23.1M | $30.4M | $38.5M | $31.7M | $41.8M | $53.3M | $65.6M | $73.2M | $83.8M | ||
| Total Revenue | $32.5M | $23.1M | $30.4M | $38.5M | $31.7M | $41.8M | $53.3M | $65.6M | $73.2M | $83.8M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $-6.2M | $-5.6M | $-7.2M | $8.8M | $8.1M | $9.8M | $12.0M | $15.4M | $16.9M | $19.5M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $26.3M | $17.5M | $23.2M | $29.7M | $23.6M | $32.0M | $41.3M | $50.2M | $56.4M | $64.3M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $-15.4M | $-16.2M | $-17.2M | $21.1M | $24.3M | $22.2M | $25.7M | $30.1M | $34.4M | $38.2M | ||
| Research & Development | $1.3M | $1.7M | $1.5M | $1.4M | $1.9M | $1.9M | $2.3M | $2.9M | $2.8M | $3.0M | ||
| Research Expense | $1.3M | $1.7M | $1.5M | $1.4M | $1.9M | $1.9M | $2.3M | $2.9M | $2.8M | $3.0M | ||
| Selling, General & Administrative | $14.1M | $14.5M | $15.7M | $19.6M | $22.4M | $20.3M | $23.4M | $27.3M | $31.6M | $35.2M | ||
| Selling & Marketing Expenses | $5.3M | $5.5M | $7.0M | $9.2M | $10.2M | $10.6M | $12.7M | $12.1M | $15.6M | $17.4M | ||
| General & Administrative Expenses | $8.8M | $9.0M | $8.7M | $10.5M | $12.3M | $9.8M | $10.7M | $15.1M | $15.9M | $17.8M | ||
| Salaries & Wages | $-1.8M | $-2.5M | $-1.8M | -- | $8.1M | $1.5M | $1.4M | -- | -- | -- | ||
| Depreciation & Amortization | $-230.3K | $-362.9K | $-470.4K | $501.2K | $510.7K | $532.3K | $569.6K | $648.1K | $585.5K | -- | ||
| Depreciation & Amortization | $-230.3K | $-362.9K | $-470.4K | $501.2K | $510.7K | $532.3K | $569.6K | -- | -- | -- | ||
| Amortization | $-18.0K | $-82.4K | $-89.3K | $90.0K | $92.9K | $101.7K | $101.1K | $117.0K | $232.1K | -- | ||
| Securities Amortization | -- | -- | -- | -- | -- | -- | $12.0M | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | $409.6K | $409.6K | $467.6K | $534.5K | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $10.9M | $1.3M | $6.0M | $8.6M | $-756.1K | $9.8M | $15.6M | $20.0M | $22.0M | $26.1M | ||
| EBITDA | $11.9M | $2.7M | $7.3M | $10.3M | $582.7K | $11.2M | $16.3M | $22.5M | $25.1M | $29.5M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | -- | -- | $9.8M | -- | -- | -- | -- | ||
| Intinc | $32.7K | $111.4K | $193.5K | $388.8K | $132.2K | $34.8K | $581.9K | $1.9M | $2.2M | $2.0M | ||
| Net Non-Operating Interest Income/Expense | $32.7K | $111.4K | $193.5K | $388.8K | $132.2K | $34.8K | $581.9K | $1.9M | $2.2M | $2.0M | ||
| Gain on Sale of Securities | $63.0K | $-6.8K | $-29.3K | $10.8K | $17.3K | $18.6K | $8.0K | -- | -- | -- | ||
| Other Income/Expense | $-61.0K | $6.8K | $29.3K | $8.4M | $8.0M | $-18.6K | $-28.7K | $-1.7M | $-2.3M | $-2.2M | ||
| Other Special Charges | $-2.0K | -- | -- | $395.9K | $139.2K | $18.6K | $553.1K | $1.7M | $2.3M | $2.2M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $9.8M | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | -- | $-8.8M | -- | $-9.8M | -- | -- | -- | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | $8.8M | $8.1M | -- | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $11.0M | $1.4M | $6.2M | $9.0M | $-756.1K | $9.8M | $15.6M | $21.7M | $24.3M | $28.4M | ||
| Pre-Tax Income | $11.0M | $1.4M | $6.2M | $9.0M | $-616.9K | $9.8M | $16.2M | $21.7M | $24.3M | $28.4M | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $3.7M | $896.6K | $-106.1K | $-587.6K | $-2.0M | $510.8K | $3.4M | $4.5M | $5.0M | $5.9M | ||
| NET INCOME | ||||||||||||
| Net Income | $7.2M | $499.8K | $6.3M | $9.6M | $1.4M | $9.3M | $12.8M | $17.2M | $19.2M | $22.5M | ||
| Net Income (Continuing Operations) | $7.2M | $499.8K | $6.3M | $9.6M | $1.4M | $9.3M | $12.8M | $17.2M | $19.2M | $22.5M | ||
| Net Income (Discontinued Operations) | $7.2M | $499.8K | $6.3M | $9.6M | $1.4M | $9.3M | $12.8M | $17.2M | $19.2M | $22.5M | ||
| Net Income (Common Stockholders) | $7.2M | $499.8K | $6.3M | $9.6M | $1.4M | $9.3M | $12.8M | $17.2M | $19.2M | $22.5M | ||
| Normalized Income | -- | -- | -- | -- | -- | $17.5M | -- | -- | -- | $27.9M | ||
| TOTALS | ||||||||||||
| Total Expenses | $-21.6M | $-21.8M | $-24.4M | $29.9M | $32.5M | $32.0M | $37.7M | $45.5M | $51.3M | $57.7M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $10.8M | $10.6M | $10.8M | $11.3M | $12.1M | $12.3M | $12.6M | $12.6M | $12.7M | $12.7M | ||
| Average Shares Outstanding (Diluted) | $12.0M | $11.7M | $12.1M | $12.3M | $12.4M | $12.6M | $12.6M | $12.7M | $12.8M | $12.9M | ||
| Shares Outstanding | $10.7M | $10.6M | $11.0M | $11.9M | $12.3M | $12.6M | $12.6M | $12.7M | $12.7M | $12.8M | ||
| Basic EPS | $0.67 | $0.05 | $0.59 | $0.85 | $0.11 | $0.76 | $1.02 | $1.36 | $1.52 | $1.77 | ||
| Basic EPS (Continuing Operations) | -- | -- | -- | $0.85 | $0.11 | $0.76 | $1.02 | $1.36 | $1.52 | $1.77 | ||
| Diluted EPS | $0.60 | $0.04 | $0.52 | $0.78 | $0.11 | $0.74 | $1.02 | $1.35 | $1.5 | $1.75 | ||
| Diluted EPS (Continuing Operations) | -- | -- | -- | $0.78 | $0.11 | $0.74 | $1.02 | $1.35 | $1.5 | $1.75 | ||
| OTHER METRICS | ||||||||||||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | -- | -- | $-12.5K | $-4.0K | $203.0K | ||
| Marketing Expense | $-136.2K | $-119.0K | $-123.5K | $156.0K | $7.0K | $95.9K | -- | -- | -- | -- | ||
| Non Recurring Operation Expense | -- | -- | -- | -- | -- | $146.0K | -- | -- | -- | -- | ||
| Other Gand A | $8.8M | $9.0M | $8.7M | $10.5M | $12.3M | $9.8M | $10.7M | $15.1M | $15.9M | $17.8M | ||
| Rent And Landing Fees | $8.8M | $9.0M | $8.7M | -- | -- | -- | -- | -- | -- | -- | ||
| Selling Expense | $5.3M | $5.5M | $7.0M | -- | -- | -- | -- | -- | -- | -- | ||
| Othspecchg | -- | -- | -- | $8.8M | -- | -- | -- | -- | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | $9.8M | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IRMD | $92.94 | +0.9% | 101.19K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |